18.37
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
[144] Zai Lab Ltd SEC Filing - Stock Titan
Zai Lab Ltd (ADR) Stock (ISIN: CA98959U1084) Faces Insider Selling Pressure Amid Earnings Anticipati - AD HOC NEWS
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Zai Lab Ltd (ADR) (ZJM, ISIN CA98959U1084) under investor scrutiny as global biotech sentiment shift - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Shares Up 9.3%Should You Buy? - MarketBeat
Affiliate sale: ZLAB (NASDAQ: ZLAB) files to sell 10,000 ADS - Stock Titan
Cantor Fitzgerald Lowers Zai Lab (NASDAQ:ZLAB) Price Target to $37.00 - Defense World
Zai Lab Q4 Earnings Call Highlights - Yahoo Finance
Zai Lab Limited 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ZLAB) 2026-02-27 - Seeking Alpha
Zai Lab (NASDAQ:ZLAB) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Zai Lab Ltd SEC 10-K Report - TradingView
Zai Lab (NASDAQ: ZLAB; 9688) lifts 2025 revenue 15% and cuts loss - Stock Titan
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - ChartMill
An Overview of Zai Lab's Earnings - Sahm
Zai Lab (ZLAB) Expected to Announce Earnings on Thursday - MarketBeat
Zai Lab Stock Pops on U.S. FDA Progress: Is Wall Street Still Too Bearish? - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Here’s What Happened - Defense World
Qiming funds disclose 4.4% Zai Lab (ZLAB) stake in amended 13G/A - Stock Titan
Zai Lab (NASDAQ:ZLAB) Shares Gap UpHere's Why - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $51.59 Consensus Price Target from Analysts - Defense World
Constellation Software Inc. (OTCMKTS:CNSWF) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Analysts Set Kraken Robotics Inc. (CVE:PNG) PT at C$7.13 - Defense World
Brokerages Set Whirlpool Corporation (NYSE:WHR) Target Price at $85.43 - Defense World
Everus Construction Group, Inc. (NYSE:ECG) Receives $102.75 Average PT from Brokerages - Defense World
FY2026 Earnings Forecast for PACCAR Issued By Zacks Research - Defense World
Plexus Corp. (NASDAQ:PLXS) Receives $189.20 Average Target Price from Analysts - Defense World
Brokerages Set Adherex Technologies Inc. (NASDAQ:FENC) PT at $14.50 - Defense World
Brokerages Set Medical Properties Trust, Inc. (NYSE:MPW) Price Target at $6.17 - Defense World
Zai Lab Limited's (NASDAQ:ZLAB) Shift From Loss To Profit - Yahoo Finance
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026 - Business Wire
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Has Lowered Expectations for Zai Lab (NASDAQ:ZLAB) Stock Price - MarketBeat
$207B Market Shift: The Race for Fast Track Approval in Oncology - Benzinga
$207B Market Shift: The Race for Fast Track Approval in Oncology - Sahm
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Hilton Food Group (LON:HFG) Insider Purchases £198,900 in Stock - Defense World
Zai Lab (NASDAQ:ZLAB) Reaches New 1-Year Low – Time to Sell? - Defense World
Is UBS’s Global-Innovation Framing Rewriting Zai Lab’s (ZLAB) Long-Term Biopharma Platform Narrative? - Sahm
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform - Finviz
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month LowHere's Why - MarketBeat
8 High Growth Chinese Stocks To Buy - Insider Monkey
Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Jefferies Financial Group - MarketBeat
Short Interest in AiRWA Inc. (NASDAQ:YYAI) Rises By 24.6% - Defense World
Short Interest in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Drops By 19.8% - MarketBeat
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update - Defense World
Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After New AUGTYRO Approval And Pipeline Progress - Sahm
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Animalcare Group (LON:ANCR) Stock Passes Below 200-Day Moving Average – Here’s What Happened - Defense World
How Investors May Respond To Zai Lab (ZLAB) Winning Expanded China Approval For AUGTYRO Cancer Therapy - Sahm
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
Lung cancer drug from Zai Lab shows 68% tumor response in early data - Stock Titan
UBS gives Zai Lab (ZLAB) a buy rating - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):